Center for Neuro-Oncology

Recent papers from Center for Neuro-Oncology

1. Artificial intelligence for symptom assessment and patient-reported outcomes in neuro-oncologyJournal of Neuro-Oncology · 2026
2. The Neuropsychological Impacts of Supratotal Glioma Resection: A Systematic ReviewNeuro-Oncology Practice · 2026
3. Management of seizures in patients with brain tumorsCurrent Opinion in Neurology · 2026
4. A 35-Year-Old Woman With Multiple Sclerosis and a New Atypical Thalamic LesionNeurology Neuroimmunology & Neuroinflammation · 2026
5. Prognostic Significance of Contrast Enhancement in Newly Diagnosed Grade 2 IDH-mutant GliomaNeuro-Oncology · 2026
6. Neoadjuvant Treatment of BRAFV600E Papillary Craniopharyngiomas: A Case SeriesOperative Neurosurgery · 2026
7. Neural Repair Therapies After Stroke: I. Therapeutic AdvancesStroke · 2026
8. Neural Repair Therapies After Stroke: II. Principles for Clinical TrialsStroke · 2026
9. Timing and prognosis of brain metastasis development in breast cancer by subtypeJNCI Cancer Spectrum · 2026
10. Neoadjuvant PD1 plus CTLA-4 immune checkpoint blockade in surgically resectable recurrent glioblastoma: a randomized surgical window-of-opportunity trialNature Communications · 2026
11. Functional Brain Network Alterations Linked to Cancer-Related Cognitive Impairment in Breast Cancer PatientsThe Oncologist · 2026
12. Spatial isoform sequencing at single-cell resolution reveals cell-type-specific spatial isoform variability in multiple brain cell typesNature Methods · 2026
13. ASTCT Consensus Grading for Toxicities after Immune Effector Cell TherapyBiology of Blood and Marrow Transplantation · 2026
14. The evolution of RTOG and NRG Oncology CNS tumors clinical trialsJournal of Neuro-Oncology · 2026
15. Spatial analysis reveals the evolving organization of IDH-mutant gliomaCancer Cell · 2026
16. Precision virotherapy for IDH-mutant astrocytomaMolecular Therapy Oncology · 2026
17. “Am I Ever Going to Find Myself Again?”: Identity Destabilization in Patients with IDH-Mutant GliomasNeuro-Oncology Practice · 2026
18. Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant gliomaScience Translational Medicine · 2026
19. Phase I Trial and Pharmacokinetic Study of Berubicin (RTA 744) in Patients with Recurrent or Refractory High-Grade GliomasNeuro-Oncology Advances · 2026
20. On the accuracy of nonlinear image registration in portable low-field 3D brain MRIScientific Reports · 2026